News & Insight

20 October 2021
News
New findings, old ideas: reviving a decades old view on the causes of cancer
Mutographs
Surprising discoveries from the Mutographs team challenge the classical view that all carcinogens directly cause mutations and suggest that non-mutagenic agents play a greater role in tumour promotion than originally thought. This story…

Latest

News
20 October 2021
Today we launch Discover: a year of scientific creativity – our annual progress magazine showcasing the power of global team science.  Discover …
News
20 October 2021
The SPECIFICANCER team delves deeper into the biological laws that govern tissue specificity in cancer and reveals intricate webs of genetic…
News
20 October 2021
A new expansion sequencing toolbox and analysis platform from the IMAXT team reveals hidden truths in biology by creating detailed nanoscale-…
News
20 October 2021
A deeper understanding of the metabolic changes during tumour development could radically change clinical decision-making and unlock opportunities to…

Latest tweet

Our keynote speaker @UriAlonWeizmann spoke (and sang) about how a career in research is not always as glamourous an… https://t.co/JpblYOWvTO Thu Oct 14 15:21:40 +0000 2021

News and insight archive

Format
Choose
Team
Choose
Tags
Choose
News
Members of the Cancer Grand Challenges Mutographs team challenge the current theory of ageing, revealing that healthy cells can tolerate many more mutations that previously assumed.  What causes us to age? A popular…
30 September 2021
News
Cancers in different parts of the body use unique strategies to avoid attack by the immune system, according to a new study from the Cancer Grand Challenges SPECIFICANCER team and collaborators. The findings also…
17 September 2021
News
How do tumours avoid attack from the immune system? For some head and neck cancers, the answer lies on the short, p, arm of chromosome 9 – findings from the Cancer Grand Challenges SPECIFICANCER team which could lead…
14 September 2021
News
We (virtually) sat down with John Marioni, new collaborator on the Cancer Grand Challenges IMAXT programme to find out more about his work. John is a senior group leader at the Cancer Research UK Cambridge Institute,…
18 August 2021
News
OPTIMISTICC’s Cindy Sears is a clinician scientist at Johns Hopkins University School of Medicine and an expert in infectious disease and colorectal cancer. In July, Cindy and the team shared a new mouse model which…
11 August 2021
News
On the surface, astronomy has little overlap with bioinformatics, mutational analysis and other areas of cancer biology. But, as described by IMAXT’s Nic Walton, an astronomer based at the University of Cambridge, there…
29 July 2021
Video
Sir Mike Stratton, based at the Wellcome Sanger Institute in Cambridge, UK, leads the Cancer Grand Challenges Mutographs team. Mutographs unites genomicists with epidemiologists, building on recent developments in…
22 July 2021
News
Earlier this year, COSMIC - the world's largest and most comprehensive resource for exploring somatic mutations in cancer - celebrated the curation of its 10 millionth mutation.  PhD student Ellie Dunstone discusses…
13 July 2021
Video
Johanna Joyce is co-investigator of the Cancer Grand Challenges IMAXT team, based in Lausanne, Switzerland.   We caught up with Johanna to learn how diverse, global collaboration is helping to unlock new information…
30 June 2021